POSTGRADUATE RESEARCH INSTITUTE cyprushost
 
 
  About PRI
  Research at PRI
  Publications
  Deferiprone
  ICOC Conference
  RAHMS Conference
  Contact PRI



 

 
 
16th ICOC - First Announcement

The 16th International Conference on Oral Chelation (ICOC)
2006
Limassol, Cyprus

Website: http://www.icoc2006.org/
Poster: ICOC 2006 poster
Mirror 1: http://www.postgraduate-research-institute-pri-cyprus.org/icoc_mirror/
Mirror 2: http://www.icoc-isocam.org/

More information to follow soon  

Provisional Program and Major Topics
 
Educational programme for Clinicians and Scientists
Oral iron chelators in the treatment of thalassemias and other diseases
Advances in the treatment of iron overload with L1- Deferiprone, Deferoxamine and their combination.
The use of effective dose protocols in iron chelation therapy.
New iron chelators under development: Deferasirox (ICL670), Deferitrin (GT-56 252), L1NAll.
Future strategies and developments in iron chelation.
Iron chelation in Sickle cell anaemia, Myelodysplasia, Haemolytic anaemia, Renal dialysis, Cancer and other diseases.
Iron metabolism and iron containing proteins in normal and disease states. 
Chemical, biochemical, pharmacological,toxicological, clinical and therapeutic aspects of iron and other metals, chelating agents and drugs and their complexes.
Conditions associated with metal imbalance, transfusions and chelating drugs.
Monitoring of chelation therapy with invasive and non-invasive methods (e.g. MRI, Squid- Biosusceptometry,"Free" iron etc)
Heavy metals and radioactive metalsñToxicity and metabolic aspects.
Diagnosis and prevention of the toxicity of chelating drugs and metal inbalance
Metal ions in health, disease and diagnostic medicine
Biology, pharmacology and toxicology of metals and chelators
Free radicals in biology and medicine: the role of antioxidants 
Recent advances in thalassaemia (all aspects)
Cancer chemotherapy and chelation
Epidemiological aspects of chelation therapy in thalassaemia and other diseases
Psychological aspects of chelation and other drug therapy in thalassaemia and other diseases
Thalassaemia patient and parents meetingñExpert panel question/answer session

 

   
 
 

Best viewed with
Internet Explorer
at 800 x 600 or higher
Last update:
24 January 2006

 
 
POSTGRADUATE RESEARCH INSTITUTE Science, Technology, Environment and Medicine
3 Ammochostou Street, CY-3021 Limassol, Cyprus
Postal address: P.O. Box 51342, CY-3504 Limassol, Cyprus
Tel: +357 25 734 615, Fax: +357 25 395 926, Email:
kontoghiorghes.g.j@pri.ac.cy
About PRIResearch at PRI  |  Publications  |  Deferiprone  |  Conferences  |  Sponsors  |  Contact PRI
 
  Copyright © 2002-2006 Postgraduate Research Institute

cyprushost

Designed by LabWell Research Laboratories